Individual results vary and are not typical
Mochi Health: Specific Patient Profiles Who Should Avoid It (and Why) Mochi Health: Specific Patient Profiles Who Should Avoid It At a glance Service type / GLP-1 telehealth (insurance + cash-pay) Primary medications offered / Semaglutide, tirzepatide, compounded GLP-1 agents Monthly membership fee / Approximately $99/month (as of early 2025) Insurance accepted / Yes, select plans BBB accreditation / Not accredited as of January 2025 FDA-cleared drugs available / Yes (Wegovy, Ozempic, Mounjaro, Zepbound) Key contraindicated profiles / MTC/MEN2 history, active eating disorder, pregnancy, severe renal/hepatic disease LegitScript status / Not certified as of January 2025 Prescriber type / Physician and nurse practitioner-staffed asynchronous + synchronous visits Compounded GLP-1 risk / Compounded semaglutide from 503A/503B pharmacies carries FDA safety warnings What Is Mochi Health and How Does It Work
For a detailed pharmacology of MT2, see our Melanotan 2 and melanocortins dossier serves as a reference
After youve filled the syringe with the correct dose, youll safely remove the drawing needle and replace it with the smaller, sterile needle intended for the injection
Compound Specifications CAS 2226025-84-1 MW 338.36 g/mol Formula C17H14F2N2O3 Purity 99% (HPLC) Documentation & Lab Use Form: Lyophilized research material Documentation: Review the product label, batch records, and applicable laboratory SOPs before accessioning
